T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Briukhovetska D, Suarez-Gosalvez J, Voigt C, Markota A, Giannou AD, Schübel M, Jobst J, Zhang T, Dörr J, Märkl F, Majed L, Müller PJ, May P, Gottschlich A, Tokarew N, Lücke J, Oner A, Schwerdtfeger M, Andreu-Sanz D, Grünmeier R, Seifert M, Michaelides S, Hristov M, König L, Loureiro Cadilha B, Mikhaylov O, Anders H-J, Rothenfußer S, Flavell RA, Cerezo-Wallis D, Tejedo C, Soengas MS, Bald

Journal title: Immunity

Journal publisher: Cell Press

Published year: 2023

DOI identifier: 10.1016/j.immuni.2022.12.010

ISSN: 1074-7613